<DOC>
	<DOCNO>NCT01229462</DOCNO>
	<brief_summary>This study evaluate safety efficacy brimonidine tartrate/timolol fix combination ( Combigan® ) compare brimonidine tartrate ( Alphagan® ) timolol patient glaucoma ocular hypertension respond well topical beta blocker .</brief_summary>
	<brief_title>Safety Efficacy Brimonidine Tartrate/Timolol Fixed Combination Patients With Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Brimonidine Tartrate , Timolol Maleate Drug Combination</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Openangle glaucoma ocular hypertension least one eye responsive topical beta blocker No anticipate wear contact lens study Active ocular disease glaucoma ocular hypertension ( eg , uveitis , ocular infection severe dry eye ) Any intraocular surgery laser ( eg , cataract surgery Lasik ) within 3 month Required regular use ocular medication except occasional use artificial tear</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>